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Marco Caporale2,3,4, Thomas Bruun Rasmussen1, Graham J Belsham1 and Anette Bøtner1*Abstract
Transplacental transmission of bluetongue virus has been shown previously for the North European strain of
serotype 8 (BTV-8) and for tissue culture or chicken egg-adapted vaccine strains but not for field strains of other
serotypes. In this study, pregnant ewes (6 per group) were inoculated with either field or rescued strains of BTV-2
and BTV-8 in order to determine the ability of these viruses to cross the placental barrier. The field BTV-2 and BTV-8
strains was passaged once in Culicoides KC cells and once in mammalian cells. All virus inoculated sheep became
infected and seroconverted against the different BTV strains used in this study. BTV RNA was detectable in the
blood of all but two ewes for over 28 days but infectious virus could only be detected in the blood for a much
shorter period. Interestingly, transplacental transmission of BTV-2 (both field and rescued strains) was demonstrated
at high efficiency (6 out of 13 lambs born to BTV-2 infected ewes) while only 1 lamb of 12 born to BTV-8 infected
ewes showed evidence of in utero infection. In addition, evidence for horizontal transmission of BTV-2 between
ewes was observed. As expected, the parental BTV-2 and BTV-8 viruses and the viruses rescued by reverse genetics
showed very similar properties to each other. This study showed, for the first time, that transplacental transmission
of BTV-2, which had been minimally passaged in cell culture, can occur; hence such transmission might be more
frequent than previously thought.Introduction
Bluetongue virus (BTV) is a member of the Orbivirus
genus within the family Reoviridae. The virus has an
RNA genome consisting of 10 separate double-stranded
(ds) RNA segments each encoding at least one protein
[1-4]. The virus particles consist of a multi-layered protein
capsid enclosing the dsRNA segments. Some 26 different
serotypes of BTV are known, including the Toggenburg
virus [5] and a recently isolated virus from Kuwait [6].
The virus serotype is determined by segment 2, encoding
VP2 [7,8]; this protein is exposed on the outer surface of
the virus particle.
The virus can infect a variety of ruminant hosts including
cattle, sheep and goats. In cattle, infection is normally
sub-clinical but in sheep a variety of clinical signs can* Correspondence: aneb@vet.dtu.dk
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distribution, and reproduction in any mediumbe observed including pyrexia, nasal discharge, salivation
and facial oedema [2,9]. Initial replication of BTV in rumi-
nants occurs within lymph nodes from where it is dissemi-
nated throughout the body. Viremia, defined as infectious
virus in blood, can last for a significant period of
time (≥ 11 days in sheep and many weeks in cattle,
see [10]) even after the induction of neutralizing antibodies;
the infectious virus is largely cell associated (see [9]).
Furthermore, BTV RNA can be detected in the blood,
by RT-PCR, for a significantly longer period of time
(e.g. 111–222 days in cattle, see [10]) than infectious
virus can be isolated [11]. It is generally only during
the viremic period that insect vectors can ingest virus,
become infected and subsequently transmit the virus
to new ruminant hosts [9,10]. Transmission of BTV from
one animal to another is normally achieved through the
bites of Culicoides midges [9,12]. Following ingestion of a
blood meal containing infectious virus, the virus replicates
within the midge and it takes approximately 10 days beforetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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host [12]. Under certain circumstances, additional routes of
virus transmission can be observed. There is some evidence
for oral transmission of BTV-8 in calves, either through
contact with an infected placenta or through ingestion of
milk “spiked” with virus [13,14]. Similarly, contact transmis-
sion of BTV-26 between goats has been suggested [15] and
infection with BTV-11 has been reported following inges-
tion of pooled colostrum in California where BTV is
endemic [16]. More importantly, certain live attenuated
BTV vaccine strains, passaged extensively in cell culture,
were observed to be capable of transplacental transmission
in both cattle and sheep [9,17,18] but early studies with
wild-type (wt) BTV did not show this property (e.g.
[19,20]). However, unexpectedly, following the introduction
of the pathogenic BTV-8 into Northern Europe in 2006, it
was observed that transplacental transmission of this virus
strain occurred in both cattle and sheep [13,21-26]. A sum-
mary of the reported information on transplacental trans-
mission of BTV in cattle and sheep has been published
[27]. The particular features of the European BTV-8 virus
which are responsible for transplacental transmission are
not known. However, this property of the virus and the
subsequent birth of viremic offspring may contribute
towards its ability to be maintained from one year to
the next (overwintering), within Northern Europe, in
the absence of an active vector population during the
winter months.
Recently it has become possible to rescue defined BTVs
using a reverse genetics system [28] which relies on using
specific RNA transcripts produced from cloned cDNA.
The primary objective of this study was to characterize
the properties, in sheep, of BTV-2 and BTV-8 (field
strains) alongside the rescued BTV-2 and BTV-8 viruses
derived from cloned cDNA. This should also determine
whether the parental viruses (grown once in Culicoides
cells (KC) and once in sheep choroid plexus (CP-TERT)
cells) and the rescued viruses (inevitably involving further
growth of the viruses in cell culture), displayed the same
growth and transmission properties. In this study, preg-
nant ewes were inoculated with the selected BTV at about
1 month pre-term. All the inoculated ewes became viremic
and seroconverted against BTV prior to parturition. The
transplacental transmission of the viruses to the lambs was
analyzed in each case.
Materials and methods
Viruses
BTV-2 wt was isolated from the spleen of an adult sheep
infected during the 2001 Sardinian outbreak of bluetongue.
This BTV-2 virus was isolated before the first vaccination
campaign, with modified live vaccines (MLV), was initiated
in 2002 (within Sardinia). Furthermore, this strain could be
differentiated from the vaccine strain using a real time PCRsystem (as described and used previously [18,29]) and
sequence analysis indicated that segments 5 and 10 of the
viral RNA are 100% identical to the BTV-2/2000 Italy field
strain and to other Mediterranean BTV-2 field strains while
they differ (by 9% in Segment 5 and 17% in segment 10)
from the BTV-2 South Africa MLV (G. Savini, unpublished
results). The BTV-2 wt isolate was passaged once in KC
cells and once in the CP-TERT cell line [30] prior to the
experiment in order to amplify the virus to a concentration
suitable for inoculation. The BTV-8 wt strain from The
Netherlands (NET2006/04) was isolated from a sheep in
2006, passaged once in KC cells and once in BHK cells at
the Institute for Animal Health, Pirbright, UK.
BTV-8 rescued by reverse genetics (termed BTV-8 rg
in this study) has been described previously [4] and was
derived from the BTV-8 NET2006/04 strain referred to
as BTV-8 wt in this study. The BTV-2 strain rescued by
reverse genetics (termed BTV-2 rg) was derived from an
Italian strain isolated from an Italian sheep infected during
the Sardinian outbreak in 2000. The isolate was originally
passaged once in embryonated eggs, once in Vero cells
and 3 times in BHK cells [31]. BTV-2 rg was rescued in
BSR cells essentially as described previously [28] with
slight modifications including a double transfection in
which BSR cells were transfected initially with transcripts
encoding VP1, VP3, VP4, NS1, VP6 and NS2 and then
underwent a second transfection which included all 10
segments after 18 h incubation. Plaques were picked when
visible by eye [4].
The virus stocks for each of the BTV strains were
titrated in BSR cells just before use and were diluted to
produce the inoculum with the following titres: BTV-2 wt
(106.5 TCID50/mL), BTV-2 rg (10
6.8 TCID50/mL), BTV-8
wt (106.6 TCID50/mL) and BTV-8 rg (10
6.7 TCID50/mL).
Animal inoculations
All experimental procedures and animal management
protocols were carried out in accordance with the require-
ments of the Danish Animal Experimentation Inspectorate,
license no. 2008/561-1541.
Twenty-eight pregnant sheep (Texel × Finuld), all born
in 2010 after the termination of the Danish Bluetongue
vaccination programme, were divided into four groups
containing 6 sheep each and a control group containing
4 sheep. Prior to the experiment, all animals were tested
and found to be negative for anti-BTV antibodies and
virus. Each ewe was confirmed by ultrasound scanning
to be carrying a single foetus. Animals in the four groups
were inoculated sub-cutaneously on the inside of the thigh
with 1 mL, containing approx. 106.7 TCID50, of one of the
four different virus strains to ensure infection of each
animal. Four control ewes were inoculated in the same way
with virus-free cell culture medium. The two groups of
ewes inoculated with BTV-2 rg and BTV-8 rg were kept in
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ments using genetically modified organisms (GMO). The
BTV-8 wt infected animals were housed in a separate
stable, while the animals infected with BTV-2 wt and the
control animals were housed within another stable but with
the two groups in two individual pens that were separated
by a walkway approximately 70 cm wide.
Sampling
After virus inoculation, the ewes were monitored daily, for
a period of 14 days, for the appearance of clinical signs and
rectal temperatures were recorded. EDTA stabilised blood
and untreated blood (for serum preparation) samples were
collected at frequent intervals (0, 3, 6, 10, 14, 22 and 29 days
post-inoculation (dpi)) in order to follow the presence of
infectious BTV, BTV RNA and anti-BTV antibodies
in the experimentally infected animals. Furthermore,
EDTA stabilised blood and untreated blood samples
were collected just after lambing and before the ewes
were euthanized one week later.
After lambing, colostral milk samples were collected
from all ewes by milking and on the following 6 days
milk samples were collected daily. All milk samples were
kept at 4 °C until analysed. Blood samples were collected
from the lambs before the uptake of colostrum and
again, 3 days post lambing (dpl) and when they were
euthanized, generally at 7 dpl. A few lambs and the
infected ewes were euthanized at 8–10 dpl but the results
are shown as 7 dpl for clarity of the figures. Lambs from 3
ewes were euthanized soon after birth due to welfare
reasons. All blood and serum samples were kept at 4 °C
until analysis.
Tissue collections
Tissue samples, from the spleen and mesenteric lymph
nodes, were collected from all BTV- inoculated animals
(sheep 5–28) at necropsy. From the lambs, brain tissue
was also collected. Just after lambing, the cotyledons
were collected from the placenta. Tissue samples were
stored at −80 °C. For detection of BTV RNA, tissue
samples were prepared by homogenization in PBS
(or 0.9% NaCl) using a ratio of 1:10, the lysates were
centrifuged at 3000 × g for 15 min and the supernatants
were stored at −80 °C until analysis.
Quantitation of infectious virus
Infectious BTV was measured within blood and milk
samples by titration as described [32].
Detection of BTV RNA
For the detection of BTV RNA, total nucleic acids were
extracted from 100 μL of milk, EDTA blood or tissue
supernatants using a MagNA pure LC Total Nucleic
Acid Isolation Kit with a MagNA pure LC robot(Roche Diagnostics, Hvidovre, Denmark) and eluted in
water (50 μL). Pan-BTV one-step quantitative RT-PCR
(RT-qPCR) assays were performed using a previously
described protocol [32-34] on the extracted nucleic acids
using an M×3005p qPCR system (Agilent Technologies,
Hørsholm, Denmark). BTV serotype-specific RT-qPCRs
were performed using the BTV2G-IAH and BTV8G-IAH
kits as described by the manufacturer (LSI, Lissieu, France).
Anti-BTV antibody detection
Anti-BTV antibodies in serum were detected using ID
Screen® Bluetongue Competition kit as described by the
manufacturer (ID vet, Montpellier, France). The level of
anti-BTV antibodies in milk samples was determined using
the ID Screen® Blue Tongue Milk Indirect kit as described
by the manufacturer (ID vet, Montpellier, France).
Results
Experimental infections
In order to examine the characteristics of the different
BTV strains in sheep, a study was performed in which
two sets of field and rescued viruses (BTV-2 and BTV-8)
were inoculated into pregnant ewes at about 4 months
of gestation (1 month prior to expected parturition).
The majority of the lambs were born around 28 dpi
(range was 17–38 days). Most (24/28) of the lambs were
born healthy with the exception of 3 which had to be
euthanized for welfare reasons (lambs 6, 16 and 25 from
sheep infected with BTV-2 wt, BTV-8 wt and BTV-2 rg
respectively) and one that was born dead (lamb 15 from a
ewe infected with BTV-8 wt).
Clinical signs in pregnant ewes after inoculation with
BTV-2 or BTV-8
Following virus inoculation, the ewes were monitored
on a daily basis for clinical signs and clear evidence
(see Figure 1) for pyrexia was apparent at 5–7 dpi in
some, but not all, of the animals which were inoculated
with BTV-2 wt and the BTV-8 wt. Weaker temperature
responses were also seen in some animals inoculated with
the BTV-2 rg and BTV-8 rg. Signs of respiratory distress
and nasal discharge were also seen in all of the 6 ewes that
received the BTV-2 wt. At 14 dpi, one of the control ewes
(sheep 4) also had an elevated rectal temperature.
Detection of BTV RNA in blood
Blood samples were collected from each of the animals
at 0, 3, 6, 10, 14, 22 and 29 dpi and analyzed for the
presence of BTV RNA using RT-qPCR assays (Figure 2).
In most (20/24) of the BTV-inoculated ewes, BTV RNA
was observed in the blood at 3 dpi, the level of viral
RNA increased further to peak levels in most animals at
6 dpi. Subsequently, the amount of BTV RNA in the
blood of these ewes gradually declined through to 29 dpi
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Figure 1 Temperature responses in BTV infected ewes. Pregnant ewes were inoculated with the indicated BTV (or none, control) on day 0.
Rectal temperatures were recorded from each animal for the following 14 days as indicated.
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ewe 20, inoculated with BTV-8 rg, BTV RNA was only
detected from 6 dpi while in sheep 28, inoculated with
BTV-2 rg, a further delayed appearance of BTV RNA in
the blood was observed. BTV RNA was not detected at
3 or 6 dpi but was present at 10 dpi and subsequently.
Furthermore, two ewes inoculated with BTV-8 wt
(sheep 11) and BTV-8 rg (sheep 17) only had detectable
levels of BTV RNA in the blood on a single sampling day
(days 10 and 6 respectively) but the virus may have been
present for a few days in each case (since sampling did not
occur every day).
Samples collected at 14 dpi were analyzed using BTV
serotype-specific RT-qPCR, and positive reactions, asanticipated, were only obtained with the expected sero-
type in each case (Table 1). Blood samples from sheep
11 and 17 were negative in these assays consistent with
the failure of the pan-BTV assays to detect BTV RNA
on this day in these two sheep.
Unexpectedly, one of the 4 negative control ewes
(sheep 4) also had BTV RNA in its blood from 10
dpi onwards (Figure 2). Use of the serotype specific
RT-qPCR assays with these samples indicated that the
sheep had become infected with BTV-2 (see Table 1);
it should be noted that the control animals were housed
in the same airspace as the BTV-2 wt inoculated ewes but
within separate pens (with a 70 cm wide passage) inside
the animal accommodation. This infection is consistent
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Figure 2 BTV RNA, detected by RT-qPCR, in blood samples collected from ewes. Pregnant ewes were infected on day 0 and blood samples
were collected on the indicated days and assayed using a Pan-BTV RT-qPCR assay. Note, the presence of BTV RNA within sheep 4, which was one
of the control animals (see text).
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(see above). The appearance of BTV RNA in the
blood and the pyrexia were delayed by about 7 days
relative to the inoculated animals and suggests direct
transmission of BTV-2 from the inoculated animals.
Viremia in BTV inoculated ewes
The presence and level of infectious BTV were determined
in blood samples taken from the inoculated ewes and are
shown in Figure 3. In general, a higher level and longer
duration of viremia was observed in sheep infected with
BTV-2 than in those infected with BTV-8. Viremia wasobserved at 3 dpi in most of the sheep inoculated with
each of the BTV-2 strains (except in sheep 5, 24 and 28)
but just in one animal (sheep 12) inoculated with the
BTV-8 wt. Furthermore, no viremia was detectable at
3 dpi in sheep which received BTV-8 rg although
BTV RNA was detectable in the blood at this stage
(see Figure 2), albeit at a fairly low level; this may be
a reflection of the difference in sensitivity of the two
different assays. At 6 dpi, infectious virus was detectable
in the blood of all 4 groups of BTV-inoculated sheep and
indeed the peak level of viremia was observed on this day
for nearly all of the BTV-inoculated ewes. By 10 dpi, the
Table 1 Serotype-specific RT-qPCR assays on blood
samples at 14 dpi.
Sheep Inoculum BTV-2 BTV-8 PanBTV
1 No virus - - -
2 - - -
3 - - -
4 * 23.01 - 19.15
5 BTV-2 wt 28.86 - 25.37
6 23.94 - 18.95
7 23.48 - 19.15
8 24.52 - 22.48
9 26.59 - 24.65
10 24.01 - 19.14
11 BTV-8 wt - - -
12 - 32.92 28.08
13 - 29.5 26.09
14 - 25.8 21.9
15 - 30.36 25.24
16 - 26.31 23.33
17 BTV-8 rg - - -
18 - 33.66 29.82
19 - 32.14 27.92
20 - 37.87 29.3
21 - 29.89 24.93
22 - 32.88 28.64
23 BTV-2 rg 27.84 - 23.96
24 31.82 - 30.06
25 28.41 - 26.91
26 30.53 - 27.87
27 27.45 - 24.63
28 28.3 - 26.55
* as indicated in text, this control ewe became infected with BTV-2.
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BTV-2 (both wt and rg strains) were still near peak levels in
many animals (Figure 3) and indeed for sheep 28 this was
the first day that BTV-2 rg appeared in the blood. However,
by 14 dpi little or no infectious virus could be detected in
the blood of most ewes although readily detectable levels of
BTV RNA remained (see Figure 2). Sheep 4, (as shown in
Figure 2) was also found to have infectious virus in its
blood by 9 dpi (Figure 3) and this was maintained at high
levels at 14 dpi, a result consistent with the unexpected de-
tection of BTV RNA in one of the control animals. The
duration and level of viremia in this animal was similar to
that seen with the sheep inoculated with the BTV-2 wt but
the development of the viremia was delayed (by about
7 days) relative to the inoculated sheep which is consistent
with the delayed appearance of BTV in the blood (Figure 2)
and the late pyrexia (Figure 1).Seroconversion against BTV
Most (18/24) of the BTV-inoculated sheep had conclusively
seroconverted against BTV by 6 dpi (as judged by ELISA)
and the antibody levels in all the remaining animals had
reached the diagnostic threshold level by 10 dpi (Figure 4).
The presence of the anti-BTV antibodies in these animals
was maintained up to the last samples analysed at 28 dpi. It
is interesting to note that this included sheep 11 and 17
which only showed a short-lived presence of BTV RNA in
the blood (see Figure 2). Comparison of the antibody
responses indicated that the sheep reacted with different
kinetics to the BTV-2 wt compared to the BTV-2 rg
(Figure 4). At 3 dpi, the antibody responses to BTV-2 wt
were lower than those observed with BTV-2 rg (p < 0.005)
(although it should be noted that all of these antibody
responses were still below the diagnostic threshold for the
assay) whereas, in contrast, at 6 dpi, the clearly seropositive
anti-BTV responses were higher (p < 0.01) in the BTV-2 wt
inoculated ewes (6 out of 6 were seropositive) than in the
ewes that received BTV-2 rg (only 2 out of these 6 were
conclusively seropositive at 6 dpi). Thus, it appears that the
antibody response, once initiated, was faster in the BTV-2
wt inoculated ewes. Analogous observations were also
made in the animals that were inoculated with BTV-8 wt
and rg viruses. At 3 dpi, there was no apparent response in
BTV-8 wt infected animals but a small response (albeit
below the diagnostic threshold) in the BTV-8 rg inoculated
ewes. At 6 and 10 dpi, significantly higher (p < 0.01
and p < 0.05 respectively) antibody responses were detect-
able in the BTV-8 wt infected animals compared to the
BTV-8 rg infected group (all the ewes inoculated with
BTV-8 wt were seropositive at 6 dpi whereas only 4 out of
6 ewes inoculated with the BTV-8 rg were seropositive at
this time). All the antibody responses were maintained
throughout the rest of the experiment (Figure 4). Among
the control animals, sheep 1, 2 and 3 remained seronegative
throughout the experiment but sheep 4 had seroconverted
by 14 dpi (but not by 10 dpi) consistent with the
delayed infection with BTV-2 in this ewe described
above (see also Figures 2 and 3).
Transplacental transmission of BTV
To assess transplacental transmission of BTV from the
ewes to the lambs, blood samples were collected from each
lamb immediately after birth (before colostrum intake) and
at 3 and 7 days of age (when possible). The presence of
BTV RNA in these samples was assessed by RT-qPCR as
above and the results are summarised in Table 2. In total, 6
lambs had BTV RNA detectable in their blood at birth.
Two lambs, born to ewes 6 and 8 inoculated with BTV-2
wt, had high levels of BTV RNA in their blood at birth; this
was maintained until euthanasia (Figure 5; but note that
lamb 6 was euthanized on day 1). In addition, 3 lambs,
born to sheep 23, 26 and 27 that had been inoculated with
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Figure 3 Infectious BTV in blood samples of inoculated ewes. Selected blood samples, collected on the indicated days, were assayed for the
presence of infectious BTV by titration on cells.
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http://www.veterinaryresearch.org/content/44/1/75the BTV-2 rg, also had high levels of BTV RNA in their
blood from birth which were maintained until euthanasia
(ca. 7 days later). Finally, the control ewe (sheep 4), shown
above to be infected with BTV-2, also produced a lamb
with BTV RNA in its blood (Table 2 and Figure 5). In con-
trast, only 1 of the 12 lambs born to BTV-8 (wt or rg)
infected ewes could be shown to carry BTV RNA at birth
(note this was determined from organ samples (see below)
since this lamb died at birth and blood samples were
not collected). None of the other lambs born to BTV-8
inoculated ewes (either wt or rg strains) had BTV-8 in
their blood (Table 2).
Blood samples from the lambs shown to contain BTV
RNA were also assayed for the presence of infectiousBTV as described above. Five lambs were shown to be
viremic at birth and lamb 4 was identified as viremic at
3 days of age (Figure 5). Lamb 6, which died shortly after
birth, had the highest level of infectious BTV in its blood.
The serum samples from the lambs were also assayed
for the presence of anti-BTV antibodies by ELISA
(see Figure 6). Only one animal (lamb 27, from a ewe
inoculated with BTV-2 rg) had clearly seroconverted
prior to birth although several others, from ewes
infected with BTV-2, were close to the diagnostic cut
off level. All of the other lambs born to the inoculated
ewes (irrespective of virus strain) were shown to have
seroconverted to BTV between birth and 3 days later
(see Figure 6), presumably due to transfer of maternal
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Figure 4 Production of anti-BTV antibodies in ewes. Serum samples collected on the indicated days from inoculated ewes were assayed for
the presence of anti- BTV antibodies using an ELISA as described in Materials and methods. The horizontal bars indicate the boundary between
positive and negative sera, values which fall within the bar are considered inconclusive.
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http://www.veterinaryresearch.org/content/44/1/75antibodies in the colostrum. Indeed milk samples, col-
lected on a daily basis after lambing, showed the presence
of anti-BTV antibodies in the milk (see Table 3) from each
of the infected ewes (including from the control sheep 4
which became infected with BTV-2). Three of the 13
BTV-2 infected ewes produced milk samples on the day
of parturition which contained BTV RNA (Table 3) and
two others produced milk that had low levels of BTV
RNA on later days. In contrast, none of the sheep inocu-
lated with BTV-8 had detectable BTV RNA in their milk
on parturition day but one (sheep 16) had detectable
BTV RNA on a later day. It should be noted that a
high proportion (10 of 12) of these ewes still hadBTV RNA in their blood (see Figure 2).This low pro-
portion of BTV positive milk samples (and the low
level of BTV RNA even in the positive samples) may
be because the virus is closely associated with eryth-
rocytes within the blood and hence not free to enter
the milk, however this does not explain the apparent
difference between the results from ewes inoculated
with BTV-2 and BTV-8.
BTV RNA in ewe tissues
All spleen samples (except for sheep 10 which was
lost), collected post-mortem from each of the BTV-
inoculated ewes were found to contain BTV RNA as
Table 2 Detection of BTV RNA by RT-qPCR in blood and tissues of lambs.
Lamb Virus Blood sample Blood sample Blood sample Spleen Mesenteric
lymph nodes
Brain Cotyledons
11 22 33
1 None - - - - - - -
2 - - - - - - -
3 - - - - - - -
4 19.32 21.3 18.5 24.86 29.71 27.28 N.D.
5 BTV-2 wt - - - - - - 28.93
6 18.08 N.D. N.D. 21.87 26.83 24.98 23.54
7 - - - - - - N.D.
8 20.82 18.88 18.91 23.48 30.84 26.87 24.25
9 - - - - - - 29.94
10 - - - N.D. N.D. N.D. 25.96
11 BTV-8 wt - - - - - - 35.05
12 - - - - - - N.D.
13 - - - - - - 28.49
14 - - - - - - 27.65
15 N.D.4 N.D.4 N.D.4 19.99 27.41 25.96 22.72
16 - - N.D. - - - N.D.
17 BTV-8 rg - - - - - - -
18 - - - - - - 33.13
19 - - - - - - 25.72
20 - - - - - - 34.26
21 - - - - - - N.D.
22 - - - - - - 26.61
23 BTV-2 rg 19.53 18.12 19.67 26.23 31.8 29.47 22.16
24 - - - - - - 31.02
25 - N.D. N.D. N.D. - - N.D.
26 22.47 21.12 20.24 26.57 30.62 30.17 25.91
27 21.1 19.28 19.29 26.08 30.75 29.47 24.49
28 - - - - - - N.D.
1: Blood sample 1 was taken soon after birth before colostrum was received.
2: Blood sample 2 was normally taken at 3dpi but was delayed in some samples.
3: Blood sample 3 was normally taken at 7 dpi but was delayed in some samples.
4: Lamb 15 died at birth.
- indicates no Ct value obtained by 50 cycles.
N.D. = not determined.
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http://www.veterinaryresearch.org/content/44/1/75assessed by RT-qPCR (Table 3). Interestingly, BTV RNA
was detected in the spleens of the 2 ewes (sheep 11 and
17) that only had a transient presence of BTV RNA in
the blood, although the Ct values were relatively high
(i.e. low levels of BTV RNA). This result appears con-
sistent with the fact that these 2 sheep seroconverted to
BTV (Figure 4). The spleen from ewe 4 (inadvertently
infected with BTV-2) also contained BTV RNA
(Table 3). In contrast, the mesenteric lymph nodes from
only 12 of the 24 BTV- infected ewes contained detect-
able BTV RNA (Table 3).BTV RNA in tissue samples from lambs
Tissue samples from brain, spleen and mesenteric lymph
nodes, collected post-mortem, from each of the lambs
born to BTV-infected mothers or mock-infected con-
trols were also tested for the presence of BTV RNA. As
expected, each of the lambs that had BTV RNA in their
blood (numbers 4, 6, 8, 23, 26 and 27; see Table 2), also
had BTV RNA in these tissues. Since lamb 15 was found
dead, no blood samples were collected but the spleen,
lymph nodes and brain from this lamb were found to
contain high levels of BTV RNA. In addition, the
BTV RNA
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Figure 5 Detection of BTV RNA and viremia in lambs. Blood samples collected from lambs on the indicated days were assayed for the
presence of BTV RNA (panel a) by RT-qPCR (as in Figure 2) and for infectious virus in cells (panel b) as for Figure 3. Note, lamb 6 was euthanized
at birth (indicated by ∞).
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http://www.veterinaryresearch.org/content/44/1/75cotyledons (a portion of the placenta) were also tested
for BTV RNA, when available, and found to be BTV
positive in 17 of the 18 samples tested (Table 2), likely as
a result of contamination from the blood of the ewes
presumably during lambing. This was in accordance with
the finding that the cotyledon samples from lambs that
had BTV RNA in their own blood generally gave lower
Ct values (i.e. higher levels of BTV RNA) compared to
the other samples.
Discussion
Each of the 4 virus strains (BTV-2 wt, BTV-2 rg, BTV-8
wt and BTV-8 rg) used in this study efficiently infected
the inoculated pregnant ewes which all became viremic
and, in most cases, the presence of viral RNA in the
blood was maintained for an extended period (>25 days)
including the time of parturition (Figures 2 and 3). In
addition, all of the infected ewes seroconverted against
the virus (Figure 4). A major focus of this study has beenthe transplacental transmission of the different viruses
and this will be discussed in detail below. In addition,
the unexpected horizontal transmission of BTV-2 is
considered. The results show that the wt and rg strains
of each serotype had very similar characteristics to each
other but the BTV-2 and BTV-8 viruses show some dif-
ferences. It was noted that BTV-2 wt produced more
marked clinical signs (including respiratory distress and
nasal discharge) than any of the other viruses and both
the BTV-2 wt and the BTV-8 wt viruses produced more
marked pyrexia than the rescued (rg) viruses. However,
the significance of this is not clear since all animals
acquired BTV RNA in their blood and seroconverted
against the virus.
Transplacental transmission of BTV-2 and BTV-8 in sheep
As described previously [27], transplacental transmis-
sion, in both cattle and sheep, is a documented property
of the North European BTV-8 strain and also of BTV
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Figure 6 Detection of anti-BTV antibodies in lambs. Sera from lambs collected prior to ingestion of colostrum (at birth) and on the indicated
days, subsequently, were assayed for the presence of anti-BTV antibodies by ELISA as in Figure 4.
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that have been extensively passaged in eggs or tissue
culture [9,17,18]. In contrast, earlier work with other
field strains of BTV (not including BTV-2) did not show
this property [19,20,27].
In this study we now show that a field strain of BTV-
2, minimally passaged in tissue culture, is able to cross
the placental barrier in experimentally infected ewes.
The BTV-2 wt virus [31] had been passaged only once
in KC cells and once in a sheep cell line and it is, there-
fore not expected to have changed its phenotype due to
mutations accumulated after extensive cell culture pas-
saging as shown for tissue culture adapted or vaccinestrains. Both BTV-2 wt and BTV-2 rg were capable of
transplacental transmission in approximately 50% of the
infected ewes. Interestingly, transplacental transmission
of BTV-2 occurred even in the negative control ewe
(sheep 4) that had been infected, inadvertently, during
co-housing with the experimentally infected sheep.
Thus, the transplacental transmission of BTV-2 does not
appear to be an artifact of the experimental inoculation
procedure per se (i.e. using sub-cutaneous inoculation of
high levels of virus).
There have been no previous reports on the transpla-
cental transmission of field strains of BTV-2 but the
clear detection of viremia in the lambs as well as the
Table 3 Detection of BTV RNA and anti-BTV antibodies in tissues and milk from ewes.
Sheep Virus Spleen Mesenteric Lymph nodes Milk (on day of parturition) Anti-BTV abs in milk
1 Control N.D. N.D. N.D. NEG
2 N.D. N.D. N.D. NEG
3 N.D. N.D. N.D. NEG
4 27.31 - 34.63 +
5 BTV-2 wt 30.07 - - +
6 23.14 31.03 29.76 +
7 24.13 33.37 - +
8 26.36 - - +
9 27.59 31.6 - +
10 N.D. N.D. N.D. +
11 BTV-8 wt 33.00 - - +
12 28.81 32.03 - +
13 28.56 35.10 - +
14 30.42 34.12 - +
15 30.59 33.04 - +
16 30.13 32.65 −1 +
17 BTV-8 rg 35.51 31.99 - +
18 29.66 - - +
19 28.32 33.98 - +
20 29.84 - - +
21 26.19 - - +
22 28.31 32.86 - +
23 BTV-2 rg 32.13 - - +
24 30.48 - - 1 +
25 28.66 - - 1 +
26 28.38 - 35.08 +
27 26.72 33.11 - +
28 26.68 - - +
1: Milk samples collected on later days contained low levels of BTV RNA but it may be that the milk was contaminated by blood from the ewe.
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clearly demonstrate this process for both the BTV-2 wt
and BTV-2 rg strains used in this study (Table 2 and
Figure 5). Recently, it has been reported that an egg and
cell culture-adapted strain of BTV-2 (used as a modified
live vaccine) is able to cross the placenta of sheep and re-
sult in infection of foetuses [18]. It remains to be deter-
mined whether BTV-2, which has only been passaged
within animals and transmitted by transfer of blood, is also
able to cross the placental barrier. The BTV-2 wt strain
used in the current study was isolated from a BTV-
infected sheep in Sardinia prior to the use of modified live
vaccine strains (from South Africa) on this island. In
addition, it has been shown, using RT-qPCR assays [29]
and genome sequencing, that this BTV-2 wt strain is dis-
tinct from the BTV-2 vaccine strain (G. Savini, unpub-
lished results).Transplacental transmission of the BTV-8 wt was
observed at a lower frequency than expected, in only 1
of the 6 ewes, and in none of the ewes infected with the
BTV-8 rg. Previous studies have indicated that transpla-
cental transmission of BTV-8 wt has occurred in sheep
[23,24] and cattle [20,35,36] but the frequency can be
quite variable varying from 0-69% in sheep [21,24,25]
and 20-35% in cattle [22,26,36]. This may depend, in
part, on the time of infection in relation to the gestation
period. It should be noted that BTV infection of ewes
during the early stages of gestation (5th and 6th week) can
have serious neurological consequences for the lambs
(see [9,18]) when transplacental transmission (e.g. with vac-
cine strains) occurs. However, studies with an attenuated
BTV-23 virus (passaged 20 times in Vero cells) in Merino
sheep [37] showed that vaccination with this live virus
(which produced no clinical disease) during the late stage
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http://www.veterinaryresearch.org/content/44/1/75of gestation had no apparent effect on the production of
lambs despite causing high losses in the first and second
thirds of the pregnancy. These data are consistent with the
results observed here using infection with both the BTV-2
and BTV-8 strains since no abnormalities were observed in
any of the lambs.
Each of the BTVs tested clearly infected the virus
inoculated sheep since all had infectious virus and BTV
RNA detectable in the blood and all of the inoculated
animals seroconverted against BTV. The serotype specific
RT-qPCR assays confirmed that the animals had indeed
been infected with the serotype of BTV used for their in-
oculation (Table 1). At the time of birth, only one of
the lambs (number 27) had conclusively seroconverted
against BTV but all lambs from BTV-infected ewes rapidly
seroconverted following ingestion of colostrum. These
results were consistent with previous studies indicating
that the presence of anti-BTV antibodies in lambs depends
on the time point during gestation at which the BTV infec-
tion occurred, when the infection is late (as in this study)
then lambs can be born viremic with or without anti-BTV
antibodies [9,24]. It was apparent that the severity of
clinical signs (elevated temperature and respiratory
distress) together with the level and period of viremia
(when infectious virus can be isolated) was much
greater in the BTV-2 inoculated sheep than in the
BTV-8 infected sheep. It may be that these features
are relevant to the probability of transplacental transmis-
sion. However, it is noteworthy that similar levels and
maintenance of BTV RNA in the blood, as measured by
RT-qPCR, were observed for all of the viruses tested and
each virus also induced seroconversion. Thus the level and
maintenance of BTV RNA within the blood are clearly not
indicative of the ability of BTV to cross the placenta.
There has been some discussion previously about the
possible role of co-infection of BTV with pestiviruses
(e.g. bovine viral diarrhea virus (BVDV) and border
disease virus (BDV)) in transplacental transmission.
Backx et al. [14] found a possible association between
the timing of seroconversion to BVDV in a single dam
and the production of a BTV positive calf. However,
Zanella et al. [35] showed that 128 (16%) fetuses/calves
analyzed in their study were BTV-8 positive but only 2
out of the 763 calves from dams that were tested were
found to be coinfected with BTV-8 and BVDV while 9
fetuses/calves were exclusively BVDV positive. Thus these
authors concluded that “BVDV did not play an important
role as a cross-barrier enhancer”. We are unaware of any
studies demonstrating a link between pestivirus infection
and BTV transplacental transmission in sheep. In Denmark,
the sheep are free from BDV and BVDV infection and,
indeed, all sera from each of the ewes were seronegative in
a BVDV ELISA (which cross reacts with antibodies against
other pestiviruses) at the start of the experiment (day 0).For one group of animals (sheep 5–10), inoculated
with BTV-2 wt, it has been shown that these animals
seroconverted against pestiviruses by 29 dpi (data not
shown). Based on a set of differentiating neutralization
tests, it appears that the antibodies detected in these 6 ani-
mals were generated against BDV rather than BVDV. All of
the other ewes remained seronegative for pestiviruses. Thus
it seems that the BTV-2 wt inoculum was contaminated
with BDV. We do not believe this has influenced the results
significantly for several reasons. As indicated above, sheep
4, one of the control sheep, unexpectedly became infected
with BTV-2 without receiving the same inoculum, however,
this ewe did not seroconvert against pestiviruses but
produced a BTV positive lamb (Table 2). Furthermore,
50% of the BTV-2 rg inoculated group (as with the BTV-2
wt group) also produced BTV infected lambs but
none of these animals seroconverted against pestiviruses
(data not shown). Thus there was no apparent linkage
between pestivirus infection and BTV-2 transplacental
transmission in this study.
Oral transmission of BTV-2 in sheep?
An interesting feature of this study was the observation
that one ewe (sheep 4), which was in the control group,
became infected with BTV-2 (see Figures 2, 3 and 4).
This sheep shared the same airspace with the sheep inocu-
lated with BTV-2 wt but was in a different pen separated
by a 70 cm wide corridor. The infection in sheep 4 was de-
layed by approximately one week compared to the directly
inoculated animals and thus it appears that transmission of
the virus has occurred between the infected animals and
this control animal. The one week time delay does not
seem sufficient for this transmission to have occurred
through midge vectors since it takes approximately 2 weeks
for ingested virus to replicate sufficiently within midges to
enable efficient transmission to occur [12]. Furthermore,
the animal isolation facilities should not allow access to
midges but their introduction with the sheep, or maybe
straw, cannot be completely excluded although the experi-
ment was performed outside of the normal vector season
within Denmark. It seems more likely that transmission oc-
curred by oral ingestion of virus, e.g. on straw contami-
nated either during the inoculation procedure of the test
group (by leaking of inoculum from inoculation site) or
from virus shed during the early stages of infection and
transferred, inadvertently, to the control group. Previous
studies have also provided some evidence that transmission
of BTV can occur between cattle and goats independently
from midges [13-16] and it seems that this has occurred by
oral transmission. It is also interesting to note that sheep 1,
which did not show any evidence for being infected with
BTV during the course of the studies presented here, had
BTV RNA in its blood at 16 days after lambing of sheep 4,
and in organs at autopsy, during a follow-up study
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with the sheep 5–28). Thus sheep 1 may also have
become infected through oral transmission of the virus
(likely via sheep 4 since the placenta of the lamb born to
this ewe was not found in the pen). Infection via contact
with an infected placenta has been described previ-
ously [13]. It is clear that a more focused analysis of
oral transmission of BTV would be useful.
Conclusions
This study shows that an Italian strain of BTV-2 minim-
ally passaged in tissue culture (once in Culicoides cells
and once in sheep cells) is able to cross the placental
barrier in infected sheep. Although theoretically possible,
it seems unlikely that the minimum passage of the virus
in cells that are derived from a host species for BTV
could change its phenotype in such a dramatic fashion.
Thus, transplacental transmission, at least for this strain of
BTV-2, might be more common than previously recognized
and one of the mechanisms by which this virus overwinters
when insect vector activity is very low.
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